The ABBV Stock Puzzle: Unraveling Abbvie Inc’s Fluctuating Performance

VIPS stock

Abbvie Inc’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $218.66 on 03/10/25 and a low of $163.52 for the same time frame on 07/03/24.

52-week price history of ABBV Stock

Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Abbvie Inc’s current trading price is -15.17% away from its 52-week high, while its distance from the 52-week low is 13.43%. The stock’s price range during the 52-week period has remained between $163.52 and $218.66. In the Healthcare sector, the company’s shares saw a trading volume of around 4.73 million for the day, which was evidently lower than the average daily volume of 7.67 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Abbvie Inc (ABBV) has experienced a quarterly decline of -13.27% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 327.63B and boasts a workforce of 55000 employees.

Making Sense of Trading Volume and Moving Average Data

Examining ABBV’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for ABBV stands at 49.22. Similarly, the long-term debt-to-equity ratio is also 45.44.

ABBV Stock Price Performance Analysis

The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The metric has seen a significant gain of 4.38% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 7.10%. Over the past 30 days, the price of ABBV has fallen by 0.79%. And in the last five days, it has fallen by -2.12%.

Most Popular

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.